Chemoinformaics analysis of 2-Methyl-2-butenyl caffeate
| Molecular Weight | 248.278 | nRot | 4 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 9 |
| Exact Molecular Weight | 248.105 | nRing | 1 |
| Solubility: LogS | -2.53 | nHRing | 0 |
| Solubility: LogP | 3.152 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 37.2567 |
| nHD | 2 | BPOL | 18.6553 |
| QED | 0.372 |
| Synth | 2.494 |
| Natural Product Likeliness | 1.284 |
| NR-PPAR-gamma | 0.832 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.093 |
| HIA | 0.008 |
| CACO-2 | -4.632 |
| MDCK | 0.0000246 |
| BBB | 0.21 |
| PPB | 0.973962 |
| VDSS | 0.746 |
| FU | 0.0470515 |
| CYP1A2-inh | 0.969 |
| CYP1A2-sub | 0.144 |
| CYP2c19-inh | 0.772 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.704 |
| CYP2c9-sub | 0.853 |
| CYP2d6-inh | 0.818 |
| CYP2d6-sub | 0.566 |
| CYP3a4-inh | 0.469 |
| CYP3a4-sub | 0.235 |
| CL | 16.351 |
| T12 | 0.937 |
| hERG | 0.012 |
| Ames | 0.288 |
| ROA | 0.694 |
| SkinSen | 0.936 |
| Carcinogencity | 0.229 |
| EI | 0.887 |
| Respiratory | 0.331 |
| NR-Aromatase | 0.549 |
| Antiviral | Yes |
| Prediction | 0.568695 |